← Eichor
Study identifier: NCT05602636 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Analgesic Effect of Supraclavicular Block and Interscalene Analgesia Versus an Intercostobrachial Nerve Block Versus PCA in Forearm Surgery

Condition: Forearm Surgery · US-Guided Supraclavicular Block · Interscalene Analgesia  ·  Sponsor: Al-Azhar University

PhasePhase 4
Planned participants60
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

The etiology of tourniquet pain is complex, and the study team hypothesizes that blocking with Interscalene brachial plexus block (ISBPB) is more efficient in decreasing the incidence of tourniquet pain in comparison with other techniques. As there is a paucity of studies that evaluate the effect of intercostobrachial nerve (ICBN) block and ISBPB and Patient-Controlled Analgesia (PCA) with a supraclavicular brachial plexus block (SCBPB) on tourniquet pain in forearm surgery, Therefore, we established this randomized study to compare ISBPB and ICBN and PCA with fentanyl with SCBPB in terms of the incidence and severity of tourniquet pain in patients undergoing forearm surgery.

This description comes directly from the study's public registry record.

Talk to the study team

Neveen A. Kohaf, Ph.D  ·  +201069482380  ·  nevenabdo@azhar.edu.eg

Always discuss trial participation with your own doctor first.

Locations (1)

Facualty of Medicine(Damietta), Al Azhar UniversityDamietta, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05602636